Revenio Group Oyj
OMXH:REG1V
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
19.81
34.96
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one REG1V stock under the Base Case scenario is 30.69 EUR. Compared to the current market price of 34.96 EUR, Revenio Group Oyj is Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Revenio Group Oyj
Run backtest to discover the historical profit from buying and selling REG1V based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Revenio Group Oyj
Balance Sheet Decomposition
Revenio Group Oyj
Current Assets | 48.3m |
Cash & Short-Term Investments | 21.5m |
Receivables | 12.6m |
Other Current Assets | 14.3m |
Non-Current Assets | 89.1m |
Long-Term Investments | 2.3m |
PP&E | 5.9m |
Intangibles | 78.1m |
Other Non-Current Assets | 2.8m |
Current Liabilities | 21.2m |
Accounts Payable | 12.4m |
Other Current Liabilities | 8.8m |
Non-Current Liabilities | 16.3m |
Long-Term Debt | 12.4m |
Other Non-Current Liabilities | 4m |
Earnings Waterfall
Revenio Group Oyj
Revenue
|
96.6m
EUR
|
Cost of Revenue
|
-47.5m
EUR
|
Gross Profit
|
49.1m
EUR
|
Operating Expenses
|
-22.8m
EUR
|
Operating Income
|
26.3m
EUR
|
Other Expenses
|
-7.2m
EUR
|
Net Income
|
19.1m
EUR
|
Free Cash Flow Analysis
Revenio Group Oyj
EUR | |
Free Cash Flow | EUR |
REG1V Profitability Score
Profitability Due Diligence
Revenio Group Oyj's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Revenio Group Oyj's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
REG1V Solvency Score
Solvency Due Diligence
Revenio Group Oyj's solvency score is 89/100. The higher the solvency score, the more solvent the company is.
Score
Revenio Group Oyj's solvency score is 89/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
REG1V Price Targets Summary
Revenio Group Oyj
According to Wall Street analysts, the average 1-year price target for REG1V is 31.5 EUR with a low forecast of 28.28 EUR and a high forecast of 34.65 EUR.
Shareholder Yield
Current shareholder yield for REG1V is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
REG1V Price
Revenio Group Oyj
Average Annual Return | 28.91% |
Standard Deviation of Annual Returns | 52.88% |
Max Drawdown | -71% |
Market Capitalization | 929.7m EUR |
Shares Outstanding | 26 592 758 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. The company is headquartered in Vantaa, Etela-Suomen and currently employs 184 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one REG1V stock under the Base Case scenario is 30.69 EUR.
Compared to the current market price of 34.96 EUR, Revenio Group Oyj is Overvalued by 12%.